HK1046236A1 - 迅速溶解的剂量形式及其生产方法 - Google Patents

迅速溶解的剂量形式及其生产方法 Download PDF

Info

Publication number
HK1046236A1
HK1046236A1 HK02107469.5A HK02107469A HK1046236A1 HK 1046236 A1 HK1046236 A1 HK 1046236A1 HK 02107469 A HK02107469 A HK 02107469A HK 1046236 A1 HK1046236 A1 HK 1046236A1
Authority
HK
Hong Kong
Prior art keywords
dosage form
making same
rapidly dissolving
dissolving dosage
relates
Prior art date
Application number
HK02107469.5A
Other languages
English (en)
Chinese (zh)
Inventor
Martani Rosa
Original Assignee
Novartis Consumer Health S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health S.A. filed Critical Novartis Consumer Health S.A.
Publication of HK1046236A1 publication Critical patent/HK1046236A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02107469.5A 1999-08-17 2000-08-14 迅速溶解的剂量形式及其生产方法 HK1046236A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99810738.7 1999-08-17
EP99810738 1999-08-17
PCT/EP2000/007934 WO2001012161A1 (en) 1999-08-17 2000-08-14 Rapidly dissolving dosage form and process for making same

Publications (1)

Publication Number Publication Date
HK1046236A1 true HK1046236A1 (zh) 2003-01-03

Family

ID=8242980

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107469.5A HK1046236A1 (zh) 1999-08-17 2000-08-14 迅速溶解的剂量形式及其生产方法

Country Status (8)

Country Link
US (1) US7182959B2 (cg-RX-API-DMAC10.html)
EP (1) EP1202716A1 (cg-RX-API-DMAC10.html)
JP (1) JP2003506480A (cg-RX-API-DMAC10.html)
AU (1) AU765526B2 (cg-RX-API-DMAC10.html)
CA (1) CA2380449A1 (cg-RX-API-DMAC10.html)
HK (1) HK1046236A1 (cg-RX-API-DMAC10.html)
TR (1) TR200200313T2 (cg-RX-API-DMAC10.html)
WO (1) WO2001012161A1 (cg-RX-API-DMAC10.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060073188A1 (en) * 1999-03-31 2006-04-06 Pierre Fabre Medicament Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
EP1414408B1 (en) * 2001-08-09 2006-03-29 Smithkline Beecham Plc Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
WO2003068604A1 (en) * 2002-02-13 2003-08-21 Weibel Michael K Drug dose-form and method of manufacture
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
JP4320217B2 (ja) * 2002-07-10 2009-08-26 剤盛堂薬品株式会社 鼻炎用経口製剤
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20070092583A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Cold remedy composition comprising zinc salts
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US20050214365A1 (en) * 2004-03-24 2005-09-29 Gulf Pharmaceutical Industries [Instant dissolving tablet composition for loratidine and desloratidine]
TWI547431B (zh) * 2004-06-09 2016-09-01 史密斯克萊美占公司 生產藥物之裝置及方法
US8101244B2 (en) * 2004-06-09 2012-01-24 Smithkline Beecham Corporation Apparatus and method for producing or processing a product or sample
US20060002594A1 (en) * 2004-06-09 2006-01-05 Clarke Allan J Method for producing a pharmaceutical product
AR051397A1 (es) 2004-10-21 2007-01-10 Novartis Ag Composicion farmaceutica
DK1804764T3 (da) * 2004-10-28 2008-09-29 Pantec Ag Fremstilling af et hurtigt henfaldende fast præparat ud fra et fast pulver og et frysetörringstrin
MX2009006699A (es) * 2006-12-21 2009-06-30 Mallinckrodt Inc Composicion y metodo para preparar tabletas oralmente disgregantes que contienen una alta dosis de ingredientes farmaceuticamente activos.
CN101686942B (zh) * 2007-06-27 2012-09-26 韩美药品株式会社 用于快速制备用于口服的崩解剂的方法及其产品
WO2010077878A1 (en) * 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US9968564B2 (en) 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
AU2010284028A1 (en) * 2009-08-17 2012-03-29 Waxtabs (Pty) Ltd Process for manufacturing tablets by using a fluent and settable matrix, and tablets obtained therewith
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
US20110105441A1 (en) * 2009-10-30 2011-05-05 Fmc Corporation Stable Orally Disintegrating Tablets Having Low Superdisintegrant
WO2011053251A1 (en) 2009-10-30 2011-05-05 Ix Biopharma Pte Ltd Fast dissolving solid dosage form
WO2011087705A2 (en) * 2009-12-22 2011-07-21 Fmc Corporation Fine particle croscarmellose and uses thereof
BR112012024432A2 (pt) 2010-03-29 2016-05-31 Ferring Bv composição farmacêutica de dissolução rápida
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CA2800251A1 (en) * 2010-05-25 2011-12-01 David Kossor Compositions and methods for reduction of mercury toxicity
JP6174585B2 (ja) 2011-09-16 2017-08-02 フェリング ベスローテン フェンノートシャップ 速溶性医薬組成物
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311490A (en) * 1980-12-22 1982-01-19 General Electric Company Diamond and cubic boron nitride abrasive compacts using size selective abrasive particle layers
DE3275121D1 (en) * 1981-12-11 1987-02-19 Wyeth John & Brother Ltd Process for preparing solid shaped articles
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
EP0524180B1 (en) * 1990-04-11 1995-04-26 The Upjohn Company Taste masking of ibuprofen by fluid bed coating
ES2202302T3 (es) * 1991-05-28 2004-04-01 Mcneil-Ppc, Inc. Composicion masticable que libera un farmaco.
RU2109509C1 (ru) * 1991-12-24 1998-04-27 Яманути Фармасьютикал Ко., Лтд. Композиция для буккального введения лекарственного средства и способ ее получения
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
WO1997038679A2 (en) * 1996-04-16 1997-10-23 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
EP0839526A3 (en) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
JPH11116466A (ja) * 1997-10-09 1999-04-27 Ss Pharmaceut Co Ltd 急速溶解型固形製剤およびその製造法
US6194395B1 (en) * 1999-02-25 2001-02-27 Orthro-Mcneil Pharmaceutical, Inc. Cyclodextrin cladribine formulations

Also Published As

Publication number Publication date
AU7275700A (en) 2001-03-13
US20020131998A1 (en) 2002-09-19
WO2001012161A1 (en) 2001-02-22
JP2003506480A (ja) 2003-02-18
US7182959B2 (en) 2007-02-27
TR200200313T2 (tr) 2002-04-22
AU765526B2 (en) 2003-09-18
EP1202716A1 (en) 2002-05-08
CA2380449A1 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
WO1997038679A3 (en) Fast disintegrating oral dosage form
TR200200313T2 (tr) Hızla çözünen dozaj formu ve bunun yapım prosesi.
CA2301135A1 (en) Rapidly disintegrating methylcellulose tablets
CA2301132A1 (en) Rapidly disintegrating methylcellulose tablets
MXPA02003596A (es) Composiciones farmaceuticas novedosas de farmacos anti tubercular y procedimiento para su preparacion.
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
HUP0401213A3 (en) Compounds effecting glucokinase, process for their preparation and their use for production of pharmaceutical compositions
WO2002015927A8 (en) High mannose proteins and methods of making high mannose proteins
CA2408848A1 (en) Rapidly disintegrating solid oral dosage form
DZ2786A1 (fr) Préparation pharmaceutique de sildénafil à délitement oral et procédé por sa production.
EP1120109A3 (en) Rapidly disintegrating and fast dissolving solid dosage form
HUP0102676A2 (hu) Szilárd, gyorsan széteső cetirizint tartalmazó gyógyszerkészítmények
MXPA04005767A (es) Formacion previa para hacer tabletas de mezclas naturales de estrogenos conjugados.
WO2002047607A3 (en) Process for the preparation of a fast dissolving dosage form
EP1595533A4 (en) RASCH IN THE MOUTHHOUSE MELTING TABLET
WO2002094774A3 (en) Oxcarbazepine dosage forms
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
AU2002360958A1 (en) METHOD FOR PRODUCING Beta MANNITOL DIRECTLY COMPRESSIBLE INTO TABLETS
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
CA2429639A1 (en) Stable azithromycin monohydrate
WO2001034118A3 (en) Solid dispersion pharmaceutical formulations
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
CA2326840A1 (en) Carvedilol-galenics
CA2399709A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
HUP0204187A3 (en) Process for the preparation of 1-oxo-1,3-dihydro-5-isobenzofurancarboxylic acid and its use for the production of citalopram